• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RAM 评分是预测肝癌肝切除术后早期死亡率和复发的有效指标。

RAM score is an effective predictor for early mortality and recurrence after hepatectomy for hepatocellular carcinoma.

机构信息

Department of Surgery, Chang Gung Memorial Hospital, No. 5, Fuxing St., Guishan Dist., Taoyuan, 333, Taiwan, Republic of China.

College of Medicine, Chang Gung University, Taoyuan, Taiwan, Republic of China.

出版信息

BMC Cancer. 2017 Nov 9;17(1):742. doi: 10.1186/s12885-017-3748-9.

DOI:10.1186/s12885-017-3748-9
PMID:29121890
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5680811/
Abstract

BACKGROUND

Liver resection had been regarded as a standard treatment for primary hepatocellular carcinoma (HCC). However, early mortality and recurrence after surgery were still of major concern. RAM (Risk Assessment for early Mortality) scoring system is a newly developed tool for assessing early mortality after hepatectomy for HCC. In this study, we compared RAM scoring system with ALBI and MELD scores for their capability of predicting short-term outcome.

METHODS

We retrospectively reviewed patients with hepatocellular carcinoma who were treated with hepatectomy at Chang Gung Memorial Hospital between 1986 and 2015. Their clinical characteristics and perioperative variables were collected. We applied RAM, albumin-bilirubin (ALBI), and model for end-stage liver disease (MELD) scoring systems to predict early mortality and early recurrence in HCC patients after surgery. We investigated the discriminative power of each scoring system by receiver operating characteristic (ROC) curve and area under the ROC curve (AUC).

RESULTS

A total of 1935 patients (78% male) who underwent liver resection for HCC were included in this study. The median follow-up period was 41.9 months. One hundred and forty-nine patients (7.7%) died within 6 months after hepatectomy (early mortality). All the three scoring systems were effective predictor for early mortality, with higher score indicating higher risk of early mortality (AUC of RAM = 0.723, p < 0.001; AUC of ALBI = 0.682, p < 0.001; AUC of MELD = 0.590, p = 0.002). Cox regression multivariate analysis demonstrated that the RAM class was the most significant independent predictor of early mortality after surgery, while MELD grade failed to discriminatively predict early mortality. In addition to early mortality, the RAM score was also predictive of early recurrence in HCC after surgery.

CONCLUSIONS

This study demonstrated that RAM score is an effective and user-friendly bedside scoring system to predict early mortality and early recurrence after hepatectomy for HCC. In addition, the predictive capability of RAM score is superior to ALBI and MELD scores. Further study is warranted to validate our findings.

摘要

背景

肝切除术一直被认为是原发性肝细胞癌 (HCC) 的标准治疗方法。然而,手术后的早期死亡率和复发仍然是主要关注点。RAM(早期死亡率风险评估)评分系统是一种新开发的用于评估 HCC 肝切除术后早期死亡率的工具。在本研究中,我们比较了 RAM 评分系统与 ALBI 和 MELD 评分系统在预测短期预后方面的能力。

方法

我们回顾性分析了 1986 年至 2015 年期间在长庚纪念医院接受肝切除术治疗的 HCC 患者。收集了他们的临床特征和围手术期变量。我们应用 RAM、白蛋白-胆红素 (ALBI) 和终末期肝病模型 (MELD) 评分系统预测 HCC 患者手术后的早期死亡率和早期复发。我们通过接收者操作特征 (ROC) 曲线和 ROC 曲线下面积 (AUC) 来研究每个评分系统的判别能力。

结果

共纳入 1935 例 (78%为男性) 接受 HCC 肝切除术的患者。中位随访时间为 41.9 个月。149 例患者 (7.7%) 在肝切除术后 6 个月内死亡 (早期死亡率)。所有三种评分系统均为早期死亡率的有效预测指标,评分越高,早期死亡率的风险越高 (RAM 评分的 AUC = 0.723,p < 0.001;ALBI 评分的 AUC = 0.682,p < 0.001;MELD 评分的 AUC = 0.590,p = 0.002)。Cox 回归多变量分析表明,RAM 分级是手术后早期死亡率的最显著独立预测因素,而 MELD 分级无法区分地预测早期死亡率。除了早期死亡率,RAM 评分还可预测 HCC 手术后的早期复发。

结论

本研究表明,RAM 评分是一种有效且易于使用的床边评分系统,可预测 HCC 肝切除术后的早期死亡率和早期复发。此外,RAM 评分的预测能力优于 ALBI 和 MELD 评分。需要进一步的研究来验证我们的发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ba1/5680811/4aad22aac7c7/12885_2017_3748_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ba1/5680811/8d91dd48d91a/12885_2017_3748_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ba1/5680811/4aad22aac7c7/12885_2017_3748_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ba1/5680811/8d91dd48d91a/12885_2017_3748_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ba1/5680811/4aad22aac7c7/12885_2017_3748_Fig2_HTML.jpg

相似文献

1
RAM score is an effective predictor for early mortality and recurrence after hepatectomy for hepatocellular carcinoma.RAM 评分是预测肝癌肝切除术后早期死亡率和复发的有效指标。
BMC Cancer. 2017 Nov 9;17(1):742. doi: 10.1186/s12885-017-3748-9.
2
Modified Child-Pugh grade albumin-bilirubin grade for predicting prognosis of hepatocellular carcinoma patients after hepatectomy.改良的 Child-Pugh 分级联合白蛋白-胆红素分级对预测肝癌患者肝切除术后预后的价值。
World J Gastroenterol. 2020 Feb 21;26(7):749-758. doi: 10.3748/wjg.v26.i7.749.
3
Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma.白蛋白-胆红素与 Child-Pugh 评分作为肝癌肝切除术后结局的预测指标。
Br J Surg. 2016 May;103(6):725-734. doi: 10.1002/bjs.10095. Epub 2016 Mar 23.
4
Ability of the ALBI grade to predict posthepatectomy liver failure and long-term survival after liver resection for different BCLC stages of HCC.ALBI 分级预测不同巴塞罗那临床肝癌分期 HCC 患者肝切除术后肝衰竭和长期生存的能力。
World J Surg Oncol. 2018 Oct 16;16(1):208. doi: 10.1186/s12957-018-1500-9.
5
The combination of the preoperative albumin-bilirubin grade and the fibrosis-4 index predicts the prognosis of patients with hepatocellular carcinoma after liver resection.术前白蛋白-胆红素分级与纤维化-4 指数联合预测肝癌患者肝切除术后的预后。
Biosci Trends. 2019;13(4):351-357. doi: 10.5582/bst.2019.01212.
6
A Comparative Study of Albumin-Bilirubin Score with Child-Pugh Score, Model for End-Stage Liver Disease Score and Indocyanine Green R15 in Predicting Posthepatectomy Liver Failure for Hepatocellular Carcinoma Patients.白蛋白-胆红素评分与Child-Pugh评分、终末期肝病模型评分及吲哚菁绿R15在预测肝细胞癌患者肝切除术后肝衰竭中的比较研究
Dig Dis. 2018;36(3):236-243. doi: 10.1159/000486590. Epub 2018 Mar 1.
7
Risk factors for early mortality after hepatectomy for hepatocellular carcinoma.肝细胞癌肝切除术后早期死亡的危险因素。
Medicine (Baltimore). 2016 Sep;95(39):e5028. doi: 10.1097/MD.0000000000005028.
8
Albumin-Bilirubin Score vs Model for End-Stage Liver Disease in Predicting Post-Hepatectomy Outcomes.白蛋白-胆红素评分与终末期肝病模型在预测肝切除术后结局中的比较。
J Am Coll Surg. 2020 Apr;230(4):637-645. doi: 10.1016/j.jamcollsurg.2019.12.007. Epub 2020 Jan 16.
9
Preoperative albumin-bilirubin grade combined with aspartate aminotransferase-to-platelet count ratio index predict outcomes of patients with hepatocellular carcinoma within Milan criteria after liver resection.术前白蛋白-胆红素分级联合天冬氨酸转氨酶-血小板计数比值指数预测米兰标准内肝癌患者肝切除术后的预后。
Biosci Trends. 2019 May 12;13(2):176-181. doi: 10.5582/bst.2019.01088. Epub 2019 Apr 27.
10
Combining albumin-bilirubin score with future liver remnant predicts post-hepatectomy liver failure in HBV-associated HCC patients.白蛋白-胆红素评分联合剩余肝体积预测乙型肝炎相关肝细胞癌患者肝切除术后肝衰竭。
Liver Int. 2018 Mar;38(3):494-502. doi: 10.1111/liv.13514. Epub 2017 Jul 28.

引用本文的文献

1
Baseline FIB-4 May Be a Risk Factor of Recurrence After SBRT in Patients With HBV-Related Small HCC.基线FIB-4可能是乙肝相关小肝癌患者接受立体定向放疗后复发的危险因素。
Cancer Med. 2025 Jan;14(1):e70535. doi: 10.1002/cam4.70535.
2
Recurrence Pattern Is an Independent Surgical Prognostic Factor for Long-Term Oncological Outcomes in Patients with Hepatocellular Carcinoma.复发模式是肝细胞癌患者长期肿瘤学结局的独立手术预后因素。
Biomedicines. 2024 Mar 14;12(3):655. doi: 10.3390/biomedicines12030655.
3
Factors affecting overall survival and disease-free survival after surgery for hepatocellular carcinoma: a nomogram-based prognostic model-a Western European multicenter study.

本文引用的文献

1
Prognostic significance of combined albumin-bilirubin and tumor-node-metastasis staging system in patients who underwent hepatic resection for hepatocellular carcinoma.白蛋白-胆红素联合肿瘤-淋巴结-转移分期系统在接受肝细胞癌肝切除患者中的预后意义。
Hepatol Res. 2017 Nov;47(12):1289-1298. doi: 10.1111/hepr.12868. Epub 2017 Mar 7.
2
Long-Term Impact of Postoperative Complications on Cancer Recurrence Following Lung Cancer Surgery.肺癌手术后并发症对癌症复发的长期影响。
Ann Surg Oncol. 2017 Apr;24(4):1135-1142. doi: 10.1245/s10434-016-5655-8. Epub 2016 Oct 26.
3
Adverse Effects of Anastomotic Leakage on Local Recurrence and Survival After Curative Anterior Resection for Rectal Cancer: A Systematic Review and Meta-analysis.
影响肝癌手术后总生存和无病生存的因素:基于列线图的预后模型——一项西欧多中心研究。
Updates Surg. 2024 Jan;76(1):57-69. doi: 10.1007/s13304-023-01656-8. Epub 2023 Oct 15.
4
Respiratory muscle training with electronic devices in the postoperative period of hepatectomy: A randomized study.肝切除术后使用电子设备进行呼吸肌训练:一项随机研究。
World J Hepatol. 2023 May 27;15(5):688-698. doi: 10.4254/wjh.v15.i5.688.
5
Laparoscopic liver resection is associated with less significant muscle loss than the conventional open approach.腹腔镜肝切除术与传统开腹手术相比,肌肉损失程度较轻。
World J Surg Oncol. 2022 Dec 4;20(1):385. doi: 10.1186/s12957-022-02854-1.
6
The Vessels That Encapsulate Tumor Clusters (VETC) Pattern Is a Poor Prognosis Factor in Patients with Hepatocellular Carcinoma: An Analysis of Microvessel Density.包裹肿瘤簇的血管(VETC)模式是肝细胞癌患者预后不良的因素:微血管密度分析
Cancers (Basel). 2022 Nov 3;14(21):5428. doi: 10.3390/cancers14215428.
7
A Retrospective Comparison of Three Patient-Controlled Analgesic Strategies: Intravenous Opioid Analgesia Plus Abdominal Wall Nerve Blocks versus Epidural Analgesia versus Intravenous Opioid Analgesia Alone in Open Liver Surgery.三种患者自控镇痛策略的回顾性比较:静脉注射阿片类药物镇痛加腹壁神经阻滞与硬膜外镇痛及单纯静脉注射阿片类药物镇痛在开放性肝脏手术中的应用
Biomedicines. 2022 Sep 27;10(10):2411. doi: 10.3390/biomedicines10102411.
8
The feasibility of transcatheter arterial chemoembolization following radiation therapy for hepatocellular carcinoma.放射治疗后经动脉化疗栓塞治疗肝细胞癌的可行性
Acta Radiol Open. 2021 Aug 4;10(7):20584601211034965. doi: 10.1177/20584601211034965. eCollection 2021 Jul.
9
A novel preoperative predictive model of 90-day mortality after liver resection for huge hepatocellular carcinoma.一种用于预测巨大肝细胞癌肝切除术后90天死亡率的新型术前预测模型。
Ann Transl Med. 2021 May;9(9):774. doi: 10.21037/atm-20-7842.
10
A simple scoring system to estimate perioperative mortality following liver resection for primary liver malignancy-the Hepatectomy Risk Score (HeRS).一种用于评估原发性肝癌肝切除术后围手术期死亡率的简单评分系统——肝切除风险评分(HeRS)。
Hepatobiliary Surg Nutr. 2021 Jun;10(3):315-324. doi: 10.21037/hbsn.2020.03.12.
吻合口漏对直肠癌根治性前切除术后局部复发和生存的不良影响:一项系统评价和Meta分析
World J Surg. 2017 Jan;41(1):277-284. doi: 10.1007/s00268-016-3761-1.
4
Risk factors for early mortality after hepatectomy for hepatocellular carcinoma.肝细胞癌肝切除术后早期死亡的危险因素。
Medicine (Baltimore). 2016 Sep;95(39):e5028. doi: 10.1097/MD.0000000000005028.
5
Albumin-Bilirubin Score: Predicting Short-Term Outcomes Including Bile Leak and Post-hepatectomy Liver Failure Following Hepatic Resection.白蛋白-胆红素评分:预测肝切除术后包括胆漏和肝切除术后肝功能衰竭在内的短期结局
J Gastrointest Surg. 2017 Feb;21(2):238-248. doi: 10.1007/s11605-016-3246-4. Epub 2016 Sep 12.
6
Prognostic value of the albumin-bilirubin grade in patients with hepatocellular carcinoma: Validation in a Chinese cohort.白蛋白-胆红素分级在肝细胞癌患者中的预后价值:在中国队列中的验证
Hepatol Res. 2017 Jul;47(8):731-741. doi: 10.1111/hepr.12796. Epub 2016 Nov 3.
7
Application of the albumin-bilirubin grade for predicting prognosis after curative resection of patients with early-stage hepatocellular carcinoma.白蛋白-胆红素分级在预测早期肝细胞癌患者根治性切除术后预后中的应用。
Clin Chim Acta. 2016 Nov 1;462:15-22. doi: 10.1016/j.cca.2016.08.005. Epub 2016 Aug 9.
8
Cancer Recurrence After Esophagectomy: Impact of Postoperative Infection in Propensity-Matched Cohorts.食管癌切除术后的癌症复发:倾向匹配队列中术后感染的影响
Ann Thorac Surg. 2016 Nov;102(5):1638-1646. doi: 10.1016/j.athoracsur.2016.04.097. Epub 2016 Jun 25.
9
Incorporating albumin-bilirubin grade into the cancer of the liver Italian program system for hepatocellular carcinoma.将白蛋白-胆红素分级纳入意大利肝癌项目系统用于肝细胞癌。
J Gastroenterol Hepatol. 2017 Jan;32(1):221-228. doi: 10.1111/jgh.13457.
10
Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade.肝功能对肝细胞癌根治性治疗的长期影响:ALBI分级的应用
Br J Cancer. 2016 Mar 29;114(7):744-50. doi: 10.1038/bjc.2016.33.